Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Non-Current Debt of $379.1 million for Q1 2026, up 14.94% year-over-year from $329.8 million in Q1 2025, and down 6.26% quarter-over-quarter from $404.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Non-Current Debt data on file, last reported at $379.1 million in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $379.1 million, up 14.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $379.1 million (up 14.94% YoY), and the FY2025 annual result was $404.4 million, up 219.1% from the prior year.
- Non-Current Debt retreated to $379.1 million in Q1 2026 per STVN's latest filing, from $404.4 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $430.3 million in Q3 2025 and troughed at -$339.5 million in Q4 2024.
- A 5-year average of $184.7 million and a median of $221.4 million in 2022 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2023 and 2025: Non-Current Debt sank 81.64% in 2023, then jumped 219.1% in 2025.
- A 5-year view of Non-Current Debt shows it stood at -$151.4 million in 2022, then slumped by 81.64% to -$275.0 million in 2023, then retreated by 23.45% to -$339.5 million in 2024, then jumped by 219.1% to $404.4 million in 2025, then dropped by 6.26% to $379.1 million in 2026.
- Business Quant data shows STVN's Non-Current Debt at $379.1 million in Q1 2026, $404.4 million in Q4 2025, and $430.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 14.71 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 12.50 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 202.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.58 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.86 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 8.62 Bn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 379.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 379.05 Mn |
| Mar 31, 2026 | 379.05 Mn |
| Dec 31, 2025 | 404.35 Mn |
| Dec 31, 2025 | 404.35 Mn |
| Sep 30, 2025 | 430.31 Mn |
| Sep 30, 2025 | 430.31 Mn |
| Jun 30, 2025 | 387.85 Mn |
| Jun 30, 2025 | 387.85 Mn |
| Mar 31, 2025 | 329.79 Mn |
| Mar 31, 2025 | 329.79 Mn |
| Dec 31, 2024 | -339.49 Mn |
| Dec 31, 2024 | -339.49 Mn |
| Sep 30, 2024 | 317.79 Mn |
| Sep 30, 2024 | 317.79 Mn |
| Jun 30, 2024 | 271.78 Mn |
| Jun 30, 2024 | 271.78 Mn |
| Mar 31, 2024 | 304.76 Mn |
| Mar 31, 2024 | 304.76 Mn |
| Dec 31, 2023 | -275.01 Mn |
| Dec 31, 2023 | -275.01 Mn |